AAIS
ONC

ABN AMRO Investment Solutions’s BeOne Medicines Ltd ONC Stock Holding History

ABN AMRO Investment Solutions’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.7M Buy
65,524
+17,960
+38% +$5.29M 0.16% 100
2026
Q1 		$14.1M Buy
47,564
+15,488
+48% +$5.01M 0.18% 105
2025
Q4 		$9.75M Buy
32,076
+16,879
+111% +$5.52M 0.14% 127
2025
Q3 		$5.18M Sell
15,197
-9,718
-39% -$2.95M 0.11% 152
2025
Q2 		$6.03M Sell
24,915
-1,645
-6% -$403K 0.12% 134
2025
Q1 		$7.23M Buy
26,560
+2,152
+9% +$503K 0.15% 120
2024
Q4 		$4.51M Sell
24,408
-1,696
-6% -$347K 0.08% 165
2024
Q3 		$5.86M Sell
26,104
-2,335
-8% -$420K 0.1% 139
2024
Q2 		$4.06M Hold
28,439
– – 0.07% 171
2024
Q1 		$4.45M Buy
28,439
+2,920
+11% +$470K 0.08% 175
2023
Q4 		$4.6M Buy
25,519
+241
+1% +$43.6K 0.08% 178
2023
Q3 		$4.55M Buy
25,278
+2,761
+12% +$546K 0.09% 179
2023
Q2 		$4.01M Buy
22,517
+1,217
+6% +$280K 0.08% 181
2023
Q1 		$4.59M Buy
+21,300
New +$5.11M 0.09% 172

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

ABN AMRO Investment Solutions's ONC Position: Q2 2026 in Review

ABN AMRO Investment Solutions increased its BeOne Medicines Ltd (ONC) stake by 38% in Q2 2026, buying an estimated $5.29M and bringing the position to 65,524 shares worth $18.7M. The position accounts for 0.16% of the portfolio, ranked #100.

ABN AMRO Investment Solutions first reported a position in ONC in Q1 2023 and has held it in 14 quarters since. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • ABN AMRO Investment Solutions held 65,524 shares of BeOne Medicines Ltd worth $18.7M as of Q2 2026.
  • ABN AMRO Investment Solutions bought 17,960 BeOne Medicines Ltd shares in Q2 2026, an estimated $5.29M.
  • BeOne Medicines Ltd made up 0.16% of ABN AMRO Investment Solutions's portfolio in Q2 2026, its #100 holding.
  • ABN AMRO Investment Solutions first reported a position in BeOne Medicines Ltd in Q1 2023 and has held it in 14 quarters since.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on ABN AMRO Investment Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.